The anti-tumor efficacy of 20(S)-protopanaxadiol, an active metabolite of ginseng, according to fasting on hepatocellular carcinoma

다국어 초록 (Multilingual Abstract)

Background: 20(S)-protopanaxadiol (20(S)-PPD), one of the main active metabolites of ginseng, performs a broad spectrum of anti-tumor effects. Our aims are to search out new strategies to enhance anti-tumor effects of natural products, including 20(S)-PPD. In recent years, fasting has been shown to be multifunctional on tumor progression. Here, the effects of fasting combined with 20(S)-PPD on hepatocellular carcinoma growth, apoptosis, migration, invasion and cell cycle were explored.
Methods: CCK-8 assay, trypan blue dye exclusion test, imagings photographed by HoloMonitorTM M4, transwell assay and flow cytometry assay were performed for functional analyses on cell proliferation, morphology, migration, invasion, apoptosis, necrosis and cell cycle. The expressions of genes on protein levels were tested by western blot. Tumor-bearing mice were used to evaluate the effects of intermittent fasting combined with 20(S)-PPD.
Results: We firstly confirmed that fasting-mimicking increased the anti-proliferation effect of 20(S)-PPD in human HepG2 cells in vitro. In fasting-mimicking culturing medium, the apoptosis and necrosis induced by 20(S)-PPD increased and more cells were arrested at G0-G1 phase. Meanwhile, invasion and migration of cells were decreased by down-regulating the expressions of matrix metalloproteinase (MMP)-2 and MMP-9 in fasting-mimicking medium. Furthermore, the in vivo study confirmed that intermittent fasting enhanced the tumor growth inhibition of 20(S)-PPD in H22 tumor-bearing mice without obvious side effects.
Conclusion: Fasting significantly sensitized HCC cells to 20(S)-PPD in vivo and in vitro. These data indicated that dietary restriction can be one of the potential strategies of chinese medicine or its active metabolites against hepatocellular carcinoma.

목차 (Table of Contents)

• ABSTRACT
• 1. Introduction
• 2. Materials and methods
• 3. Results
• 4. Discussion
• References

참고문헌 (Reference)

1 Global Burden of Disease Liver Cancer C, "The burden of primary liver cancer and underlying etiologies from 1990to 2015 at the global, regional, and national level : results from the global burden of disease study 2015" 3 : 1683-1691, 2017

2 Khemlina G, "The biology of Hepatocellular carcinoma : implications for genomic and immune therapies" 16 : 149-, 2017

3 Rimassa L, "Systemic treatment options in hepatocellular carcinoma" 8 : 427-446, 2019

4 Di Tano M, "Synergistic effect of fastingmimicking diet and vitamin C against KRAS mutated cancers" 11 : 2332-, 2020

5 Kudo M, "Recent advances in systemic therapy for hepatocellular carcinoma in an aging society : 2020 update" 9 : 640-662, 2020

6 Wang CZ, "Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer" 7 : 799-814, 2015

7 De Mattia E, "Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma" 25 : 3870-3896, 2019

8 Liu Q, "Overexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activation" 9 : 541-549, 2013

9 McClure CD, "Hormesis results in trade-offs with immunity" 68 : 2225-2233, 2014

10 Liu B, "HP-CagAþ regulates the expression of CDK4/CyclinD1 via reg3 to change cell cycle and promote cell proliferation" 21 : 2019

11 Allemani C, "Global surveillance of trends in cancer survival 2000-14(CONCORD-3) : analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322population-based registries in 71 countries" 391 : 1023-1075, 2018

12 Peng B, "Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway" 142 : 1-13, 2019

13 조한태 ; Dongmin Jang ; 박선규 ; Mi-Gi Lee ; Byungsun Cha ; Chaewon Park ; Yong Sub Shin ; Hyein Park ; Jin-myoung Baek ; Hyojin Heo ; Sofia Brito ; 현규환 ; 채세현 ; Shao-wei Yan ; 이창호 ; Churl K. Min ; 빈범호, "Ginsenoside 20(S)-protopanaxadiol induces cell death in human endometrial cancer cells via apoptosis" 고려인삼학회 45 (45): 126-133, 2021

14 Jiang N, "Ginsenoside 20(S)-protopanaxadiol attenuates depressive-like behaviour and neuroinflammation in chronic unpredictable mild stress-induced depressive rats" 393 : 112710-, 2020

15 Di Biase S, "Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity" 30 : 136-146, 2016

16 Caffa I, "Fasting-mimicking diet and hormone therapy induce breast cancer regression" 583 : 620-624, 2020

17 Safdie F, "Fasting enhances the response of glioma to chemo-and radiotherapy" 7 : e44603-, 2012

18 Cheng AL, "Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma : a phase III randomised, double-blind, placebo-controlled trial" 10 : 25-34, 2009

19 Jordan S, "Dietary intake regulates the circulating inflammatory monocyte pool" 178 : 1102-1114, 2019

20 Bacevic K, "Cdk2strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage" 7 : 13429-, 2017

21 Li Z, "Activation of MMP-9 by membrane type-1MMP/MMP-2 axis stimulates tumor metastasis" 108 : 347-353, 2017

22 Brandhorst S, "A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan" 22 : 86-99, 2015

23 Kaili Lin ; Bin Liu ; Sze-Lam Lim ; Xiuqiong Fu ; Stephen C.-W. Sze ; Ken K.-L. Yung ; Shiqing Zhang, "20(S)-protopanaxadiol promotes the migration, proliferation, and differentiation of neural stem cells by targeting GSK-3 in the Wnt/GSK-3 / -catenin pathway" 고려인삼학회 44 (44): 475-482, 2020

24 Lu Z, "20(S)-Protopanaxadiol induces apoptosis in human hepatoblastoma HepG2 cells by downregulating the protein kinase B signaling pathway" 15 : 1277-1284, 2018